Revises provisions relating to nicotine products. (BDR 32-989)
SB435 revises Nevada’s laws governing nicotine and vapor products by creating a state certification-and-directory system for vapor product manufacturers and the products they sell. Beginning in 2026, manufacturers that want their vapor products sold in Nevada must certify to the Attorney General that each product complies with federal FDA marketing authorization requirements, identify each brand/product/flavor, and pay annual fees. The Department of Taxation must then maintain a public online directory of approved manufacturers and products, and only products listed in that directory may be sold in the state after the bill’s phase-in period.
The bill also adds enforcement tools and penalties. It authorizes notice-and-cure procedures before removal from the directory, requires retailers and wholesalers to respond to directory changes, mandates compliance checks, creates an enforcement account funded by fees and penalties, and allows seizure and destruction of noncompliant vapor products. In addition, SB435 prohibits the sale or furnishing of products containing a “nicotine analogue,” expands seizure authority for certain nicotine products sold without a license, and increases penalties for violations, including civil fines, misdemeanor liability for false certifications, and possible license suspension or revocation.
SB435 would significantly expand Chapter 370 of NRS by adding a new regulatory framework for vapor products, including manufacturer certifications, product listing requirements, retailer/wholesaler compliance obligations, enforcement authority, and a dedicated enforcement account. It also amends existing youth-access and recordkeeping provisions to cover vapor products more explicitly and to allow seizure of certain products sold in violation of licensing or age-related restrictions. The bill requires new administrative duties for the Attorney General and Department of Taxation, including directory maintenance, annual reporting, rulemaking, and compliance inspections, and it appropriates state funds to support implementation.
The available vote history suggests the bill had majority support in the Senate, passing final passage on May 29, 2025 by a 17-4 vote. No committee transcript excerpts were provided, so there is no recorded discussion to indicate specific arguments for or against the measure. Based on the structure of the bill, the overall tone appears to be regulatory and enforcement-oriented, with supporters likely viewing it as a public-health and compliance measure aimed at limiting unlawful nicotine products and opponents likely concerned about the burden on manufacturers and retailers.
The main points of contention are likely to be the scope and strictness of the vapor-product directory system, the fees and bonding requirements imposed on manufacturers, and the enforcement powers granted to state and local officers. Manufacturers and industry participants may object to the certification requirements, product-by-product listing, and the risk of removal from the directory for technical or reporting deficiencies. Retailers and wholesalers may also be affected by short compliance windows, inventory pullback requirements, and the possibility of seizure and penalties for selling products not listed in the directory. Another likely area of debate is the bill’s ban on nicotine analogues, which uses a broad definition that could raise questions about enforcement and product classification.